Table 1 Most frequently visited trial protocols between 1 August and 31 December 2008
Study acronym | Full study title | Average weekly hits |
|---|---|---|
SUCCESS | Simultaneous study of gemcitabine-docetaxel combination adjuvant treatment, as well as extended bisphosphonate and surveillance-trial | 1,548 |
GAIN - GBG 33 | A study to compare ETC vs. EC-TX and ibandronate vs. observation in patients with node-positive primary breast cancer | 1,008 |
FACE | Comparison trial of letrozole and anastrozole in the adjuvant treatment of postmenopausal women with hormone receptor and node positive breast cancer | 488 |
NATAN | Postoperative use of zoledronic acid in breast cancer patients after neoadjuvant chemotherapy | 469 |